---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-23-001290"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2023-07-11T23:59:59+00:00"
generated_at: "2026-06-13T10:00:01.955175+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enochian Biosciences receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received Nasdaq deficiency notice on July 7, 2023, for failing minimum bid price requirement.
- Closing bid price below $1.00 for 30 consecutive business days prior to notice.
- Has 180 days, until January 3, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by Jan 3, 2024, may be eligible for an additional 180-day period if other standards are met.
- Company is monitoring bid price and considering options to regain compliance.

## SEC filing metadata
- accession: 0001731122-23-001290
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2023-07-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112223001290/0001731122-23-001290-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112223001290/e4860_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-23-001290
- JSON: https://secwatch.observer/filing/0001731122-23-001290.json
- Plain text: https://secwatch.observer/filing/0001731122-23-001290.txt

## Key facts
- Listing & Compliance Notices
  Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: July 7, 2023, Enochian Biosciences Inc. (the “ Company ”) received a deficiency notice from The Nasdaq Stock Market (“ Nasdaq ”) informing the Company that its common stock, par value $0.0001 per share (the “ Common Stock ”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice from Nasdaq. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112223001290/0001731122-23-001290-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.